State-of-the-art ventilator developed in Pakistan
Prototype handed over to Innovation and Testing Centre for clinical trials
Innovation and Testing Centre will test the prototype for around two weeks as clinical trials will be carried out and then pass it over to DRAP for approval. PHOTO: EXPRESS
A prototype of a locally developed ventilator, equipped with all features available in imported ones, was handed over to the Innovation and Testing Centre (I&TC) of the Pakistan Engineering Council (PEC) on Thursday.
The centre will test the prototype called AVB-100 for nearly two weeks as clinical trials will be carried out and then pass it over to the Drug Regulatory Authority Pakistan (Drap) for approval as registered medical equipment fit for use in Pakistan, an official statement said.
LAHORE: A vital medicine used for heart-related chest pain (angina) is short in the market across Punjab.
Manufactured by a multinational pharmaceutical company, the life-saving medicine, Angised (0.5mg), was the only available remedy in an emergency. A patient feeling chest pain/heart pain (angina) is suggested to keep it under the tongue to prevent risk to life.
Senior cardiologists and surgeons said the shortage was all over the country and its main reason might be the low price. They held the retailers and distributors responsible for the shortage.
However, there was another opinion that the globally recognised pharmaceutical company had either halted its production or limited it because of some other reasons.
LAHORE: A vital medicine used for heart-related chest pain (angina) is short in the market across Punjab.
Manufactured by a multinational pharmaceutical company, the life-saving medicine, Angised (0.5mg), was the only available remedy in an emergency. A patient feeling chest pain/heart pain (angina) is suggested to keep it under the tongue to prevent risk to life.
Senior cardiologists and surgeons said the shortage was all over the country and its main reason might be the low price. They held the retailers and distributors responsible for the shortage.
However, there was another opinion that the globally recognised pharmaceutical company had either halted its production or limited it because of some other reasons.